11-36593011-G-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BA1BS2_Supporting

This summary comes from the ClinGen Evidence Repository: The NM_000536.4:c.1158C>A variant in RAG2 is a missense variant predicted to cause substitution of phenylalanine by leucine at amino acid 386 (p.Phe386Leu). This variant has a population max filtering allele frequency of 0.01649 in the European (non-Finnish) population in gnomAD, which is above the threshold for BA1 set by the ClinGen SCID VCEP for RAG2 (>0.00872). In addition, this variant is present in 23 homozygotes in gnomAD (BS2_Supporting). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive SCID based on the ACMG criteria applied: BA1 and BS2_Supporting as specified by the ClinGen SCID VCEP (VCEP specifications version 1). LINK:https://erepo.genome.network/evrepo/ui/classification/CA293061/MONDO:0000573/124

Frequency

Genomes: 𝑓 0.010 ( 17 hom., cov: 32)
Exomes 𝑓: 0.015 ( 190 hom. )

Consequence

RAG2
ENST00000311485.8 missense

Scores

4
11
2

Clinical Significance

Benign reviewed by expert panel B:14

Conservation

PhyloP100: 1.58

Publications

14 publications found
Variant links:
Genes affected
RAG2 (HGNC:9832): (recombination activating 2) This gene encodes a protein that is involved in the initiation of V(D)J recombination during B and T cell development. This protein forms a complex with the product of the adjacent recombination activating gene 1, and this complex can form double-strand breaks by cleaving DNA at conserved recombination signal sequences. The recombination activating gene 1 component is thought to contain most of the catalytic activity, while the N-terminal of the recombination activating gene 2 component is thought to form a six-bladed propeller in the active core that serves as a binding scaffold for the tight association of the complex with DNA. A C-terminal plant homeodomain finger-like motif in this protein is necessary for interactions with chromatin components, specifically with histone H3 that is trimethylated at lysine 4. Mutations in this gene cause Omenn syndrome, a form of severe combined immunodeficiency associated with autoimmune-like symptoms. [provided by RefSeq, Jul 2008]
RAG1 (HGNC:9831): (recombination activating 1) The protein encoded by this gene is involved in activation of immunoglobulin V-D-J recombination. The encoded protein is involved in recognition of the DNA substrate, but stable binding and cleavage activity also requires RAG2. Defects in this gene can be the cause of several diseases. [provided by RefSeq, Jul 2008]
RAG1 Gene-Disease associations (from GenCC):
  • immunodeficiency disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Omenn syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Genomics England PanelApp, Ambry Genetics
  • recombinase activating gene 1 deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • combined immunodeficiency due to partial RAG1 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BS2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000311485.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RAG2
NM_000536.4
MANE Select
c.1158C>Ap.Phe386Leu
missense
Exon 2 of 2NP_000527.2
RAG2
NM_001243785.2
c.1158C>Ap.Phe386Leu
missense
Exon 3 of 3NP_001230714.1
RAG2
NM_001243786.2
c.1158C>Ap.Phe386Leu
missense
Exon 3 of 3NP_001230715.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RAG2
ENST00000311485.8
TSL:1 MANE Select
c.1158C>Ap.Phe386Leu
missense
Exon 2 of 2ENSP00000308620.4
RAG1
ENST00000534663.1
TSL:1
n.*130G>T
non_coding_transcript_exon
Exon 10 of 10ENSP00000434610.1
RAG1
ENST00000534663.1
TSL:1
n.*130G>T
3_prime_UTR
Exon 10 of 10ENSP00000434610.1

Frequencies

GnomAD3 genomes
AF:
0.0102
AC:
1552
AN:
152164
Hom.:
17
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00287
Gnomad AMI
AF:
0.0527
Gnomad AMR
AF:
0.00766
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.0106
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0167
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.00967
AC:
2431
AN:
251334
AF XY:
0.00951
show subpopulations
Gnomad AFR exome
AF:
0.00339
Gnomad AMR exome
AF:
0.00249
Gnomad ASJ exome
AF:
0.00238
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0133
Gnomad NFE exome
AF:
0.0167
Gnomad OTH exome
AF:
0.00750
GnomAD4 exome
AF:
0.0153
AC:
22401
AN:
1461846
Hom.:
190
Cov.:
31
AF XY:
0.0149
AC XY:
10820
AN XY:
727222
show subpopulations
African (AFR)
AF:
0.00242
AC:
81
AN:
33480
American (AMR)
AF:
0.00264
AC:
118
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00199
AC:
52
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00123
AC:
106
AN:
86258
European-Finnish (FIN)
AF:
0.0144
AC:
767
AN:
53388
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5768
European-Non Finnish (NFE)
AF:
0.0185
AC:
20594
AN:
1111996
Other (OTH)
AF:
0.0112
AC:
677
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1354
2708
4062
5416
6770
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
768
1536
2304
3072
3840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0102
AC:
1551
AN:
152282
Hom.:
17
Cov.:
32
AF XY:
0.00945
AC XY:
704
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.00286
AC:
119
AN:
41564
American (AMR)
AF:
0.00765
AC:
117
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5182
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4818
European-Finnish (FIN)
AF:
0.0106
AC:
113
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0167
AC:
1135
AN:
68016
Other (OTH)
AF:
0.00426
AC:
9
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
84
168
252
336
420
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0139
Hom.:
67
Bravo
AF:
0.0100
TwinsUK
AF:
0.0178
AC:
66
ALSPAC
AF:
0.0187
AC:
72
ESP6500AA
AF:
0.00250
AC:
11
ESP6500EA
AF:
0.0141
AC:
121
ExAC
AF:
0.0103
AC:
1244
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.0125
EpiControl
AF:
0.0143

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
3
not specified (3)
-
-
2
Histiocytic medullary reticulosis (2)
-
-
1
Inborn error of immunity;CN257931:Recombinase activating gene 2 deficiency (1)
-
-
1
Recombinase activating gene 2 deficiency (1)
-
-
1
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive (1)
-
-
1
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;C2673536:Combined immunodeficiency with skin granulomas (1)
-
-
1
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;C2673536:Combined immunodeficiency with skin granulomas;C2700553:Histiocytic medullary reticulosis (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.81
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Uncertain
-0.080
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.82
D
Eigen
Uncertain
0.63
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.93
D
MetaRNN
Benign
0.011
T
MetaSVM
Uncertain
0.72
D
MutationAssessor
Uncertain
2.9
M
PhyloP100
1.6
PrimateAI
Uncertain
0.73
T
PROVEAN
Uncertain
-2.8
D
REVEL
Pathogenic
0.80
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.020
D
Polyphen
0.99
D
Vest4
0.80
MutPred
0.56
Gain of catalytic residue at F386 (P = 0.0875)
MPC
0.47
ClinPred
0.020
T
GERP RS
4.5
Varity_R
0.74
gMVP
0.65
Mutation Taster
=77/23
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34629171; hg19: chr11-36614561; API